Newark Beth Israel — Newark, New Jersey

Newark Beth Israel is a clinical research site located in Newark, New Jersey, United States 07112.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Newark Beth Israel has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Severe, Symptomatic, Calcific Aortic Stenosis.

Sponsors: Edwards Lifesciences, Medtronic Cardiac Rhythm and Heart Failure, Spark Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Newark Beth Israel?

Newark Beth Israel has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Newark Beth Israel conducted?

Newark Beth Israel has 8 clinical trials on record, with 2 currently active. Their work covers Severe, Symptomatic, Calcific Aortic Stenosis.

Is Newark Beth Israel accredited by Crixeo Health?

Yes — Newark Beth Israel holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Newark Beth Israel?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.